Form 4: Tenon Medical CTO Converts RSUs, Sells Shares for Tax

Tenon Medical's Chief Technology Officer, Richard Ginn, converted restricted stock units into common stock and subsequently sold a portion to cover tax obligations.

Summary

• Richard Ginn, Chief Technology Officer and Director of Tenon Medical, Inc., reported changes in beneficial ownership.
• On January 1, 2026, 126,577 restricted stock units (RSUs) granted on October 13, 2025, were converted into 126,577 shares of common stock.
• Following this conversion, Richard Ginn's beneficial ownership was 133,015 shares of common stock.
• On January 5, 2026, 47,426 shares of common stock were disposed of at a price of $0.9301 per share.
• These shares were sold to pay tax liability associated with the vesting of the RSUs.
• After these transactions, Richard Ginn's direct beneficial ownership stands at 85,589 shares of common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving RSU vesting and a subsequent tax-related sale, which is a neutral event for company operations or strategic direction.

Positives

• The vesting of 126,577 restricted stock units represents a compensation event for the Chief Technology Officer, converting contingent rights into actual shares.

Negatives

• The sale of 47,426 shares, although for tax purposes, reduces the direct equity stake of the Chief Technology Officer in the company.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a routine insider transaction report (Form 4) detailing changes in beneficial ownership for an executive, which is common across all publicly traded industries as part of executive compensation and tax planning.

Stakeholder Impact

• Shareholders: The transaction represents a minor reduction in direct insider ownership, which is a common occurrence for tax purposes following RSU vesting. It does not indicate a change in company fundamentals.
• Employees: The RSU vesting is part of executive compensation, which is standard practice.

Key Dates

Keywords

Tenon Medical, TNON, Richard Ginn, CTO, Restricted Stock Units, RSU, Insider Transaction, Stock Sale, Beneficial Ownership, Form 4